COVID-19 Vaccine policies for pregnant and lactating people worldwide.

Centers for Disease Control and Prevention

Last reviewed on 2023-01-06
Public Health Authority | United States | Virgin Islands (US)

Most recent vaccine policy positions

Name (Click to sort descending)Pregnancy (Click to sort ascending)Lactation (Click to sort ascending)
Johnson & Johnson Janssen COVID-19 vaccine
Moderna COVID-19 vaccine
Novavax Covovax, TAK-019
Oxford-AstraZeneca Vaxzevria, Covishield
Pfizer/BioNTech Comirnaty

Resources & guidance

Document type (Click to sort ascending) Vaccines (Click to clear sorting) Pregnancy (Click to sort ascending) Subgroups (Click to clear sorting) Pregnancy Booster (Click to clear sorting) Lacation (Click to sort ascending) Date (Click to sort ascending) (Click to clear sorting)
Guidance statement
2022-10-20
Guidance statement
2022-07-14
Guidance statement
2022-04-19
Guidance statement
2022-04-19
Guidance statement
2022-03-03
Guidance statement
2022-02-18
Guidance statement
2022-02-18
Guidance statement
2021-12-06
Guidance statement
2021-11-08
Guidance statement
2021-10-19
Press release
(none specified)
2021-09-29
Guidance statement
2021-08-11
Guidance statement
2021-06-29
Guidance statement
2021-06-09
Guidance statement
2021-05-14
Guidance statement
2021-05-14
Fact sheet
2021-03-19
Guidance statement
2021-03-05

Important links

https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html
https://www.cdc.gov/vaccines/covid-19/info-by-product/clinical-considerations.html
https://www.covid19usvi.com/vaccines
Legend
Recommended for some or all
Permitted
Permitted with qualifications
Not recommended but with exceptions
Not recommended
No position found
The COMIT policy tracker was developed with support from the Bill & Melinda Gates Foundation and Wellcome .

Citation

Berman Institute of Bioethics & Center for Immunization Research, Johns Hopkins University. Covid-19 Maternal Immunization Tracker (COMIT). www.comitglobal.org. Accessed: 12/5/2024, 2:48:06 AM.

Contact

If you have questions or comments, or would like to notify us of any technical issues you are experiencing with COMIT, please get in touch . We welcome and appreciate your valuable feedback.